Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats. (Q40347592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Benjamin Horrocks

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Mahasen A Radwan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Lidija Šiller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

language of work or name

English

0 references

publication date

1 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

40-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

9 April 2020

start time

1 January 2017

1 reference

https://api.crossref.org/v1/works/10.1080/10717544.2016.1228715

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Cytotoxicity of amphotericin B-incorporated polymeric micelles composed of poly(DL-lactide-co-glycolide)/dextran graft copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Effects of the aggregation state of amphotericin B on its toxicity to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Lipid-based amphotericin B formulations: from animals to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of absorption carrier for the ceftriaxone complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Bioactivity and toxicity studies of amphotericin B incorporated in liquid crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Amphotericin B nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Chemical modification of hydrophobic block in poly(ethylene oxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Development of amphotericin B loaded polymersomes based on (PEG)(3)-PLA co-polymers: Factors affecting size and in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Formulation of amphotericin B as nanosuspension for oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Amphotericin B: side effects and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

In situ forming parenteral drug delivery systems: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Nanosomal Amphotericin B is an efficacious alternative to Ambisome for fungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Development and characterization of oral liposomes of vegetal ceramide based amphotericin B having enhanced dry solubility and solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Single-dose liposomal amphotericin B for visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Production methods and stabilization strategies for polymer-based nanoparticles and microparticles for parenteral delivery of peptides and proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Amphotericin B formulations and drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Controlled release of simvastatin-loaded thermo-sensitive PLGA-PEG-PLGA hydrogel for bone tissue regeneration: in vitro and in vivo characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717544.2016.1228715

10.1080/10717544.2016.1228715

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28155565%20AND%20SRC:MED&resulttype=core&format=json